Huperzine induces alteration in oxidative balance and antioxidants in a guinea pig model

Neuroendocrinology Letters

Volumn 32, Issue SUPPL. 1, 2011, Pages 95-100

  Pohank, Miroslav ^a,b   Hrabinova, Martina ^a   Zemek, Filip ^a   Drtinova, Lucie ^a   Bandouchova, Hana ^c   Pikula, Jiri ^c  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^c UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

Author keywords

Acetylcholinesterase; Alzheimer's disease; Antioxidant; Huperzine; Inhibition; Neurodegenerative disorders; Oxidative stress

Indexed keywords

ANTIOXIDANT; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HUPERZINE A; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBELLUM; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG POTENCY; FRONTAL LOBE; GUINEA PIG; KIDNEY; LIVER; NONHUMAN; OXIDATIVE STRESS; PARIETAL LOBE; PROTEIN EXPRESSION; SPLEEN; TEMPORAL LOBE; TONIC CLONIC SEIZURE;

EID: 84857400037     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Alabarse PV, Hackenhaar FS, Medeiros TM, Mendes MF, Viacava PR, Schuller AK, Salomon TB, Ehrenbrink G, Benfato MS (2011) Oxidative stress in the brain of reproductive male rats during aging. Exp Gerontol. In press. PMID: 20971183.
2. Agarwal R, Goel SK, Behari JR (2010) Detoxification and antioxidant effects of curcumin in rats experimentally exposed to mercury. J Appl Toxicol 30: 457-468.
3. Bai D (2007) Development of huperzine A and B for treatment of Alzheimer's disease. Pure Appl Chem. 79: 469-479.
4. Bonner LT, Peskind ER (2002) Pharmacologic treatments of dementia. Med Clin North Am. 86: 657-674. (Pubitemid 34810654)
5. Coleman BR, Ratcliffe RH, Oguntayo SA, Shi X, Doctor BP, Gordon RK, Nambiar MP (2008) [+]-Huperzine A treatment protects against N-methyl-D-aspartate-induced seizure/status epilepticus in rats. Chem Biol Interact. 175: 387-395.
6. Desilets AR, Gickas JJ, Dunican KC (2009) Role of huperzine A in the treatment of Alzheimer's disease. Ann Pharmacother. 43: 514-518.
7. Gasparova Z, Snirc V, Stolc S, Dubovicky M, Mach M, Ujhazy E (2010) Maternal treatment of rats with the new pyridoindole antioxidant during pregnacy and lactation resulting in improved offspring hippocampal resistance to ischemia in vitro. Neuro Endocrinol Lett. 31: 348-352.
8. Garcia GE, Hicks RP, Skanchy D, Moorad-Doctor DR, Doctor BP, Ved HS (2004) Identification and characterization of the major huperzine a metobolite in rat blood. J Anal Toxicol. 28: 379-383. (Pubitemid 38944117)
9. Greggio S, Rosa RM, Dolganov A, de Oliveira IM, Menegat FD, Henriques JA, Dacosta JC (2009) NAP prevents hippocampal oxidative damage in neonatal rats subjected to hypoxia-induced seizures. Neurobiol Dis. 36: 435-444.
10. Haigh JR, Johnston SR, Peppernay A, Mattern PJ, Garcia GE, Doctor BP, Gordon RK, Aisen PS (2008) Protection of red blood cell acetylcholinesterase by oral huperzine A against ex vivo soman exposure: next generation prophylaxis and sequestering of acetylcholinesterase over butyrylcholinesterase. Chem Biol Interact. 175: 380-386.
11. Hoque MA, Uraji M, Banu MN, Mori IC, Nakamura Y, Murata Y (2010) The effects of methylglyoxal on glutathione S-transferase from Nicotiana tabacum. Biosci Biotechnol Biochem. 74: 2124-2126.
12. Kaplan B, Cetin F, Elbeg S (2010) The effects of vitamin C administration, acute food deprivation, and acute food intake on vitamin C levels in different brain areas of guinea pigs. Int J Vitam Nutr Res. 80: 197-204.
13. Kiran B, Karkucak M, Ozan H, Yakut T, Ozerkan K, Sag S, Ture M (2010) GST (GSTM1, GSTT1 and GSTP1) polymorphisms in the genetic susceptibility of Turkish patients to cervical cancer. J Gynecol Oncol. 21: 169-173.
14. Lim WH, Goodger JQ, Field AR, Holtum JA, Woodrow IW (2010) Huperzine alkaloids from Australasian and southeast Asian Huperia Pharm Biol. 48: 1073-1078.
15. Limon-Pacheco JH, Gonsebalt ME (2010) The glutathione system and its regulation by neurohormone melatonin in the central nervous system. Cent Nerv Syst Agents Med Chem. 10: 287-297.
16. Little JT, Walsh S, Aisen PS (2008) An update on huperzine A as a treatment for Alzheimer's disease. Expert Opin Investig Drugs. 17: 209-215. (Pubitemid 351578201)
17. Lykkesfeldt J (2007) Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking. Clin Chim Acta. 380: 50-58.
18. Milatovic D, Gupta RC, Aschner M (2006) Anticholinesterase toxicity and oxidative stress. TheScientificWorld J. 6: 295-310.
19. Myers TM, Sun W, Saxena A, Doctor BP, Bonvillain AJ, Clark MG (2010) Systematic administration of the potential countermeasure huperzine reversibly inhibits central and peripheral acetylcholinesterase activity without adverse cognitive-behavioral effects. Pharmacol Biochem Behav. 94: 477-481.
20. Pohanka M, Pejchal J, Horackova S, Kuca K, Bandouchova H, Damkova V, Pikula J (2010) Modulation of ionising radiation generated oxidative stress by HI-6 (asoxime) in a laboratory rat model. Neuro Endocrinol Lett. 31(Suppl2): 62-68.
21. Pohanka M, Sobotka J, Svobodova H, Stetina R (2011) Investigation of oxidative stress in blood, brain, kidney, and liver after oxime antidote HI-6 application in a mouse experimental model. Drug Chem Toxicol. 34: 85-91.
22. Pohanka M, Sobotka J, Stetina R. Sulfur mustard induced oxidative stress and its alteration by epigallocatechin gallate. Toxicol Lett. DOI: 10.1016/J.toxlet.2010.12.011.
23. Pohanka M, Sobotka J, Jilkova M, Stetina R (2011) Oxidative stress after sulfur mustard intoxication and its reduction by melatonin: efficacy of antioxidant therapy during serious intoxication. Drug Chem Toxicol. 34: 85-91.
24. Rafi MS, Walsh S, Little JT, Behan K, Reynolds B, Ward C, Jin S, Thomas R, Aisen PS (2011) A phase II trial of huperzine A in mild to moderate Alzheimer disease. Neurology 76: 1389-1394.
25. Rahman Q, Abidi P, Afaq F, Schiffmann D, Mossman BT, Kamp DW, Athar M (1999) Glutathione redox system in oxidative lung injury. Crit Rev Toxicol. 29: 543-568.
26. Su B, Wang X, Nunomura A, Moreira Pl, Lee H, Perry G, Smith MA, Zhu X (2008) Oxidative stress signaling in Alzheimer's disease. Curr Alzheimer Res 5: 525-532.
27. Wang BS, Wang H, Wei ZH, Song YY, Zhang L, Chen HZ (2009) Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzehimer's disease: an updated meta-analysis. J Neural Transm. 116: 457-465.
28. Wang ZF, Tang XC (2007) Huperzine A protects C6 rat glioma cells against oxygen-glucose deprivation-induced injury. FEBS Lett. 581: 596-602. (Pubitemid 46216285)
29. Zhang RW, Tang XC, Han YY, Sang GW, Zhang YD, Ma YX, Zhang CL, Yang RM (1991) Drug evaluation of huperzine A in the treatment of senile memory disorders. Zhongguo Yao Li Xue Bao 12: 250-252.